Literature DB >> 11512582

Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy.

H Hanyu1, T Asano, H Sakurai, M Takasaki, H Shindo, K Abe.   

Abstract

We measured the magnetisation transfer ratio (MTR) in the subcortical grey and white matter of 11 patients with idiopathic Parkinson's disease (PD) without dementia, six with PD with dementia (PDD), six with progressive supranuclear palsy (PSP), and 12 elderly control subjects to assess regional differences in structural brain damage. There were no significant differences in MTR in any region between PD and controls. However, patients with PDD had significantly lower MTR in the subcortical white matter, including the frontal white matter and the genu of the corpus callosum than the controls, whereas PSP had significantly lower MTR in the subcortical grey matter, including the putamen, globus pallidus and thalamus, in addition to the subcortical white matter. This suggests that regional patterns of structural brain damage can be detected using the magnetisation transfer technique. Measurement of MTR in the subcortical grey and white matter may be useful in differential diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11512582     DOI: 10.1007/s002340100558

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

2.  Magnetization transfer changes of grey and white matter in Parkinson's disease.

Authors:  N Tambasco; G P Pelliccioli; P Chiarini; G E Montanari; F Leone; M L Mancini; M Paciaroni; V Gallai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

3.  Magnetization transfer MR imaging demonstrates degeneration of the subcortical and cortical gray matter in Huntington disease.

Authors:  A Ginestroni; M Battaglini; S Diciotti; R Della Nave; L N Mazzoni; C Tessa; M Giannelli; S Piacentini; N De Stefano; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2010-09-02       Impact factor: 3.825

Review 4.  Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies.

Authors:  Hai Cun Shi; Jian Guo Zhong; Ping Lei Pan; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Hua Liang Li; Yuan Ying Song; Gui Xiang He; Hong Ye Li
Journal:  Neurol Sci       Date:  2013-03-30       Impact factor: 3.307

5.  Substantia innominata: MR findings in Parkinson's disease.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Shigeru Ehara; Takashi Abe
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

6.  Subcortical biophysical abnormalities in patients with mood disorders.

Authors:  A Kumar; S Yang; O Ajilore; M Wu; R Charlton; M Lamar
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

Review 7.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

8.  Comparison of regional brain atrophy and cognitive impairment between pure akinesia with gait freezing and Richardson's syndrome.

Authors:  Jin Yong Hong; Hyuk Jin Yun; Mun Kyung Sunwoo; Jee Hyun Ham; Jong-Min Lee; Young H Sohn; Phil Hyu Lee
Journal:  Front Aging Neurosci       Date:  2015-09-29       Impact factor: 5.750

9.  Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.

Authors:  Roland Wiest; Jean-Marc Burgunder; Claus Kiefer
Journal:  Front Neurol       Date:  2017-09-06       Impact factor: 4.003

10.  Magnetization transfer imaging in 'premanifest' Huntington's disease.

Authors:  Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.